Summary of Study ST000695
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000492. The data can be accessed directly via it's Project DOI: 10.21228/M8G31N This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST000695 |
Study Title | Pilot metabolomics study of aromatase inhibitor associated arthralgias |
Study Type | MS analysis |
Study Summary | The goal of the experiment is untargeted metabolomic and shotgun lipidomic profiling of serum samples collected from 50 patients before patients initiated therapy with an aromatase inhibitor and again after 3 months of aromatase inhibitor therapy. Half of the patients discontinued treatment within 6 months because of development of arthralgias during therapy and half remained on therapy for at least 24 months without development of significant arthralgias. We plan to analyse effects of AI therapy on metabolomic and lipidomic profiles, and to investigate associations between changes in profiles and development of symptoms. |
Institute | University of Michigan |
Department | Biomedical Research Core Facilities |
Laboratory | Metabolomics core |
Last Name | Kachman |
First Name | Maureen |
Address | 6300 Brehm Tower, 1000 Wall Street, Ann Arbor, MI 48105-5714 |
mkachman@med.umich.edu | |
Phone | (734) 232-8175 |
Submit Date | 2017-06-19 |
Num Groups | 11 |
Total Subjects | 51 |
Raw Data Available | Yes |
Raw Data File Type(s) | wiff |
Analysis Type Detail | LC-MS |
Release Date | 2017-12-06 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000492 |
Project DOI: | doi: 10.21228/M8G31N |
Project Title: | Metabolomic Profiles and aromatase inhibitor associated arthralgias |
Project Type: | MS analysis |
Project Summary: | Performing metabolomic and lipidomic profiling of patients before and after aromatase inhibitor therapy in order to investigate the mechanism of action of AI therapy and why a subset of patients develop arthralgias during therapy |
Institute: | University of Michigan |
Department: | Internal Medicine Hematology Oncology |
Laboratory: | Henry Lab |
Last Name: | Henry |
First Name: | Nora Lynn |
Address: | Ann Arbor, MI |
Email: | norahh@umich.edu |
Phone: | 734-936-4991 |
Subject:
Subject ID: | SU000718 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Species Group: | Mammals |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|
SA039318 | S00016272 | Case | N | Exemestane | Black | 3 Month | N | N |
SA039319 | S00016271 | Case | N | Exemestane | Black | Baseline | N | N |
SA039320 | S00016304 | Case | N | Exemestane | White | 3 Month | N | N |
SA039321 | S00016334 | Case | N | Exemestane | White | 3 Month | N | N |
SA039322 | S00016330 | Case | N | Exemestane | White | 3 Month | N | N |
SA039323 | S00016286 | Case | N | Exemestane | White | 3 Month | Y | N |
SA039324 | S00016280 | Case | N | Exemestane | White | 3 Month | Y | N |
SA039325 | S00016300 | Case | N | Exemestane | White | 3 Month | Y | N |
SA039326 | S00016329 | Case | N | Exemestane | White | Baseline | N | N |
SA039327 | S00016333 | Case | N | Exemestane | White | Baseline | N | N |
SA039328 | S00016303 | Case | N | Exemestane | White | Baseline | N | N |
SA039329 | S00016285 | Case | N | Exemestane | White | Baseline | Y | N |
SA039330 | S00016279 | Case | N | Exemestane | White | Baseline | Y | N |
SA039331 | S00016299 | Case | N | Exemestane | White | Baseline | Y | N |
SA039332 | S00016284 | Case | N | Letrozole | Black | 3 Month | N | N |
SA039333 | S00016283 | Case | N | Letrozole | Black | Baseline | N | N |
SA039334 | S00016278 | Case | N | Letrozole | White | 3 Month | N | N |
SA039335 | S00016308 | Case | N | Letrozole | White | 3 Month | N | N |
SA039336 | S00016250 | Case | N | Letrozole | White | 3 Month | Y | N |
SA039337 | S00016338 | Case | N | Letrozole | White | 3 Month | Y | N |
SA039338 | S00016244 | Case | N | Letrozole | White | 3 Month | Y | N |
SA039339 | S00016277 | Case | N | Letrozole | White | Baseline | N | N |
SA039340 | S00016307 | Case | N | Letrozole | White | Baseline | N | N |
SA039341 | S00016337 | Case | N | Letrozole | White | Baseline | Y | N |
SA039342 | S00016249 | Case | N | Letrozole | White | Baseline | Y | N |
SA039343 | S00016243 | Case | N | Letrozole | White | Baseline | Y | N |
SA039344 | S00016310 | Case | Y | Exemestane | Black | 3 Month | N | Y |
SA039345 | S00016309 | Case | Y | Exemestane | Black | Baseline | N | Y |
SA039346 | S00016274 | Case | Y | Exemestane | White | 3 Month | N | Y |
SA039347 | S00016320 | Case | Y | Exemestane | White | 3 Month | N | Y |
SA039348 | S00016298 | Case | Y | Exemestane | White | 3 Month | N | Y |
SA039349 | S00016316 | Case | Y | Exemestane | White | 3 Month | N | Y |
SA039350 | S00016282 | Case | Y | Exemestane | White | 3 Month | Y | N |
SA039351 | S00016336 | Case | Y | Exemestane | White | 3 Month | Y | N |
SA039352 | S00016328 | Case | Y | Exemestane | White | 3 Month | Y | Y |
SA039353 | S00016260 | Case | Y | Exemestane | White | 3 Month | Y | Y |
SA039354 | S00016297 | Case | Y | Exemestane | White | Baseline | N | Y |
SA039355 | S00016273 | Case | Y | Exemestane | White | Baseline | N | Y |
SA039356 | S00016319 | Case | Y | Exemestane | White | Baseline | N | Y |
SA039357 | S00016315 | Case | Y | Exemestane | White | Baseline | N | Y |
SA039358 | S00016335 | Case | Y | Exemestane | White | Baseline | Y | N |
SA039359 | S00016281 | Case | Y | Exemestane | White | Baseline | Y | N |
SA039360 | S00016327 | Case | Y | Exemestane | White | Baseline | Y | Y |
SA039361 | S00016259 | Case | Y | Exemestane | White | Baseline | Y | Y |
SA039362 | S00016294 | Case | Y | Letrozole | White | 3 Month | Y | Y |
SA039363 | S00016270 | Case | Y | Letrozole | White | 3 Month | Y | Y |
SA039364 | S00016312 | Case | Y | Letrozole | White | 3 Month | Y | Y |
SA039365 | S00016293 | Case | Y | Letrozole | White | Baseline | Y | Y |
SA039366 | S00016311 | Case | Y | Letrozole | White | Baseline | Y | Y |
SA039367 | S00016269 | Case | Y | Letrozole | White | Baseline | Y | Y |
SA039368 | S00016292 | Control | N | Exemestane | Black | 3 Month | Y | N |
SA039369 | S00016291 | Control | N | Exemestane | Black | Baseline | Y | N |
SA039370 | S00016248 | Control | N | Exemestane | White | 3 Month | N | N |
SA039371 | S00016262 | Control | N | Exemestane | White | 3 Month | N | N |
SA039372 | S00016326 | Control | N | Exemestane | White | 3 Month | N | N |
SA039373 | S00016296 | Control | N | Exemestane | White | 3 Month | N | N |
SA039374 | S00016268 | Control | N | Exemestane | White | 3 Month | N | N |
SA039375 | S00016332 | Control | N | Exemestane | White | 3 Month | Y | N |
SA039376 | S00016267 | Control | N | Exemestane | White | Baseline | N | N |
SA039377 | S00016261 | Control | N | Exemestane | White | Baseline | N | N |
SA039378 | S00016325 | Control | N | Exemestane | White | Baseline | N | N |
SA039379 | S00016247 | Control | N | Exemestane | White | Baseline | N | N |
SA039380 | S00016295 | Control | N | Exemestane | White | Baseline | N | N |
SA039381 | S00016331 | Control | N | Exemestane | White | Baseline | Y | N |
SA039382 | S00016302 | Control | N | Letrozole | Black | 3 Month | N | N |
SA039383 | S00016301 | Control | N | Letrozole | Black | Baseline | N | N |
SA039384 | S00016266 | Control | N | Letrozole | White | 3 Month | N | N |
SA039385 | S00016288 | Control | N | Letrozole | White | 3 Month | N | N |
SA039386 | S00016242 | Control | N | Letrozole | White | 3 Month | N | N |
SA039387 | S00016252 | Control | N | Letrozole | White | 3 Month | Y | N |
SA039388 | S00016254 | Control | N | Letrozole | White | 3 Month | Y | N |
SA039389 | S00016240 | Control | N | Letrozole | White | 3 Month | Y | N |
SA039390 | S00016241 | Control | N | Letrozole | White | Baseline | N | N |
SA039391 | S00016265 | Control | N | Letrozole | White | Baseline | N | N |
SA039392 | S00016287 | Control | N | Letrozole | White | Baseline | N | N |
SA039393 | S00016251 | Control | N | Letrozole | White | Baseline | Y | N |
SA039394 | S00016239 | Control | N | Letrozole | White | Baseline | Y | N |
SA039395 | S00016253 | Control | N | Letrozole | White | Baseline | Y | N |
SA039396 | S00016322 | Control | Y | Exemestane | White | 3 Month | N | N |
SA039397 | S00016258 | Control | Y | Exemestane | White | 3 Month | N | N |
SA039398 | S00016264 | Control | Y | Exemestane | White | 3 Month | N | Y |
SA039399 | S00016290 | Control | Y | Exemestane | White | 3 Month | N | Y |
SA039400 | S00016306 | Control | Y | Exemestane | White | 3 Month | Y | N |
SA039401 | S00016324 | Control | Y | Exemestane | White | 3 Month | Y | N |
SA039402 | S00016314 | Control | Y | Exemestane | White | 3 Month | Y | N |
SA039403 | S00016246 | Control | Y | Exemestane | White | 3 Month | Y | Y |
SA039404 | S00016257 | Control | Y | Exemestane | White | Baseline | N | N |
SA039405 | S00016321 | Control | Y | Exemestane | White | Baseline | N | N |
SA039406 | S00016289 | Control | Y | Exemestane | White | Baseline | N | Y |
SA039407 | S00016263 | Control | Y | Exemestane | White | Baseline | N | Y |
SA039408 | S00016305 | Control | Y | Exemestane | White | Baseline | Y | N |
SA039409 | S00016313 | Control | Y | Exemestane | White | Baseline | Y | N |
SA039410 | S00016323 | Control | Y | Exemestane | White | Baseline | Y | N |
SA039411 | S00016245 | Control | Y | Exemestane | White | Baseline | Y | Y |
SA039412 | S00016256 | Control | Y | Letrozole | White | 3 Month | Y | N |
SA039413 | S00016276 | Control | Y | Letrozole | White | 3 Month | Y | Y |
SA039414 | S00016318 | Control | Y | Letrozole | White | 3 Month | Y | Y |
SA039415 | S00016255 | Control | Y | Letrozole | White | Baseline | Y | N |
SA039416 | S00016275 | Control | Y | Letrozole | White | Baseline | Y | Y |
SA039417 | S00016317 | Control | Y | Letrozole | White | Baseline | Y | Y |
Collection:
Collection ID: | CO000712 |
Collection Summary: | - |
Sample Type: | Blood |
Treatment:
Treatment ID: | TR000732 |
Treatment Summary: | - |
Sample Preparation:
Sampleprep ID: | SP000725 |
Sampleprep Summary: | - |
Sampleprep Protocol Filename: | A003_-_Untargeted_Metabolomics.pdf |
Combined analysis:
Analysis ID | AN001075 | AN001076 | AN001077 | AN001078 |
---|---|---|---|---|
Analysis type | MS | MS | MS | MS |
Chromatography type | Reversed phase | Reversed phase | Reversed phase | Reversed phase |
Chromatography system | Agilent | Agilent | Shimadzu CTO-20A Nexera X2 | Shimadzu CTO-20A Nexera X2 |
Column | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) |
MS Type | ESI | ESI | ESI | ESI |
MS instrument type | QTOF | QTOF | Triple TOF | Triple TOF |
MS instrument name | Agilent 6530 QTOF | Agilent 6530 QTOF | ABI Sciex 5600+ TripleTOF | ABI Sciex 5600+ TripleTOF |
Ion Mode | NEGATIVE | POSITIVE | NEGATIVE | POSITIVE |
Units | peak area | peak area | peak area normalized | peak area normalized |
Chromatography:
Chromatography ID: | CH000758 |
Instrument Name: | Agilent |
Column Name: | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH000759 |
Instrument Name: | Shimadzu CTO-20A Nexera X2 |
Column Name: | Waters Acquity HSS T3 (50 x 2.1mm,1.8um) |
Column Temperature: | 55 |
Flow Rate: | 0.400uL/min |
Solvent A: | 40% acetonitrile/60% water; 10 mM ammonium acetate |
Solvent B: | 10% acetonitrile/5% water/85% isopropanol; 10 mM ammonium acetate |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS000970 |
Analysis ID: | AN001075 |
Instrument Name: | Agilent 6530 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
Ion Mode: | NEGATIVE |
Analysis Protocol File: | A003_-_Untargeted_Metabolomics.pdf |
MS ID: | MS000971 |
Analysis ID: | AN001076 |
Instrument Name: | Agilent 6530 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
Ion Mode: | POSITIVE |
Analysis Protocol File: | A003_-_Untargeted_Metabolomics.pdf |
MS ID: | MS000972 |
Analysis ID: | AN001077 |
Instrument Name: | ABI Sciex 5600+ TripleTOF |
Instrument Type: | Triple TOF |
MS Type: | ESI |
Ion Mode: | NEGATIVE |
Analysis Protocol File: | A004_-_Shotgun_Lipidomics.pdf |
MS ID: | MS000973 |
Analysis ID: | AN001078 |
Instrument Name: | ABI Sciex 5600+ TripleTOF |
Instrument Type: | Triple TOF |
MS Type: | ESI |
Ion Mode: | POSITIVE |
Analysis Protocol File: | A004_-_Shotgun_Lipidomics.pdf |